Elevated plasma sTIM-3 levels in severe Covid-19 patients

Further Publications DermatologyFurther Publications ImmunologyFurther Publications Rheumatology

Capturing patient-reported outcomes during the COVID-19 pandemic: Development of the COVID-19 Global Rheumatology Alliance Patient Experience Survey

Arthritis Care Res (Hoboken).

Sirotich E, Dillingham S, Grainger R, Hausmann JS, COVID-19 Global Rheumatology Alliance Steering Committee.

doi: 10.1002/acr.24257.

Immune ResponseFurther Publications Immunology

Chemokines and Eicosanoids Fuel the Hyperinflammation Within the Lungs of Patients with Severe COVID-19

J Allergy Clin Immunol

Zaid Y, Doré É, Dubuc I, Archambault AS, Flamand O, Laviolette M, Flamand N, Boilard É, Flamand L

doi: 10.1016/j.jaci.2021.05.032

Allergic Diseases

Clinical characteristics of 182 pediatric COVID-19 patients with different severities and allergic status

Allergy.

Du H, Dong X, Zhang JJ, Cao YY, Akdis M, Huang PQ, Chen HW, Li Y, Liu GH, Akdis CA, Lu XX, Gao YD

doi: 10.1111/all.14452.

Further Publications Dermatology

A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia

N Engl J Med

Simonovich VA, Burgos Pratx LD, Scibona P, Beruto MV, Vallone MG, Vázquez C, Savoy N, Giunta DH, Pérez LG, Sánchez MDL, Gamarnik AV, Ojeda DS, Santoro DM, Camino PJ, Antelo S, Rainero K, Vidiella GP, Miyazaki EA, Cornistein W, Trabadelo OA, Ross FM, Spotti M, Funtowicz G, Scordo WE, Losso MH, Ferniot I, Pardo PE, Rodriguez E, Rucci P, Pasquali J, Fuentes NA, Esperatti M, Speroni GA, Nannini EC, Matteaccio A, Michelangelo HG, Follmann D, Lane HC, Belloso WH, PlasmAr Study Group.

doi: 10.1056/NEJMoa2031304

Systemic Lupus Erythematosus

Epigenetic dysregulation of ACE2 and interferon-regulated genes might suggest increased COVID-19 susceptibility and severity in lupus patients

Clin Immunol.

Sawalha AH, Zhao M, Coit P, Lu Q

doi: 10.1016/j.clim.2020.108410.

T Cells

Histopathological findings and viral tropism in UK patients with severe fatal COVID-19: a post-mortem study

Lancet Microbe.

Hanley B, Naresh KN, Roufosse C, Nicholson AG, Weir J, Cooke GS, Thursz M, Manousou P, Corbett R, Goldin R, Al-Sarraj S, Abdolrasouli A, Swann OC, Baillon L, Penn R, Barclay WS, Viola P, Osborn M

doi: 10.1016/S2666-5247(20)30115-4.

Immune Response

Longitudinal hematologic and immunologic variations associated with the progression of COVID-19 patients in China

J Allergy Clin Immunol.

Chen R, Sang L, Jiang M, Yang Z, Jia N, Fu W, Xie J, Guan W, Liang W, Ni Z, Hu Y, Liu L, Shan H, Lei C, Peng Y, Wei L, Liu Y, Hu Y, Peng P, Wang J, Liu J, Chen Z, Li G, Zheng Z, Qiu S, Luo J, Ye C, Zhu S, Zheng J, Zhang N, Li Y, He J, Li J, Li S, Zhong N, Medical Treatment Expert Group for COVID-19

doi: 10.1016/j.jaci.2020.05.003.

Further Publications DermatologyFurther Publications ImmunologyFurther Publications Rheumatology

COVID-19 in rheumatic disease patients on immunosuppressive agents

Semin Arthritis Rheum.

Sharmeen S, Elghawy A, Zarlasht F, Yao QP

doi: 10.1016/j.semarthrit.2020.05.010.

Further Publications DermatologyFurther Publications ImmunologyFurther Publications Rheumatology

Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation: an open-label cohort study

Ann Rheum Dis.

Della-Torre E, Campochiaro C, Cavalli G, De Luca G, Napolitano A, La Marca S, Boffini N, Da Prat V, Di Terlizzi G, Lanzillotta M, Rovere Querini P, Ruggeri A, Landoni G, Tresoldi M, Ciceri F, Zangrillo A, De Cobelli F, Dagna L, SARI-RAF Study Group., SARI-RAF Study Group members.

doi: 10.1136/annrheumdis-2020-218122.

Related content

Capturing patient-reported outcomes during the COVID-19 pandemic: Development of the COVID-19 Global Rheumatology Alliance Patient Experience Survey

Chemokines and Eicosanoids Fuel the Hyperinflammation Within the Lungs of Patients with Severe COVID-19

Clinical characteristics of 182 pediatric COVID-19 patients with different severities and allergic status

A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia

Epigenetic dysregulation of ACE2 and interferon-regulated genes might suggest increased COVID-19 susceptibility and severity in lupus patients

Histopathological findings and viral tropism in UK patients with severe fatal COVID-19: a post-mortem study

Longitudinal hematologic and immunologic variations associated with the progression of COVID-19 patients in China

COVID-19 in rheumatic disease patients on immunosuppressive agents

Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation: an open-label cohort study